Type of security: Stock
Sector: Health Care
Market Capitalization: 80.39 M
The data is delayed by 15 minutes.
EDAP is in the medium-term up 79% in 1 year.
Description: EDAP TMS S.A., through its subsidiaries, develops, produces, and markets minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services. The High Intensity Focused Ultrasound division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It also offers Ablatherm, a HIFU-based device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. In addition, this division leases equipment; sells disposables and spare parts; and offers maintenance services. The Urology Devices and Service division develops, markets, manufactures, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||25.44 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||Sales Growth - Q/Q||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||-57.59||ROA||ROE||ROI|
|Current Ratio||Quick Ratio||Long Term Debt/Equity||Debt Ratio|
|Gross Margin||Operating Margin||Net Profit Margin||Dividend Payout Ratio|
|Cash From Financing Activities||6.04 M||Cash From Investing Activities||-1.03 M||Cash From Operating Activities||-1.01 M||Gross Profit||2.58 M|
|Net Profit||-2.44 M||Operating Profit||-620 K||Total Assets||32.15 M||Total Current Assets||26.61 M|
|Total Current Liabilities||12.16 M||Total Debt||5.25 M||Total Liabilities||17.01 M||Total Revenue||6.22 M|
|High 52 week||5.31||Low 52 week||1.51||Last close||4.7||Last change||3.98%|
|RSI||57.25||Average true range||0.27||Beta||0.44||Volume||60.6 K|
|Simple moving average 20 days||3.83%||Simple moving average 50 days||21.89%||Simple moving average 200 days||39.57%|
|Performance Week||-2.69%||Performance Month||16.34%||Performance Quart||76.69%||Performance Half||-8.38%|
|Performance Year||83.59%||Performance Year-to-date||154.05%||Volatility daily||2.97%||Volatility weekly||6.64%|
|Volatility monthly||13.61%||Volatility yearly||47.15%||Relative Volume||248.4%||Average Volume||204.04 K|
|New High||New Low|
2020-05-13 16:35:00 | EDAP Reports First Quarter 2020 Results and Provides Operational Update
2020-05-06 08:30:00 | EDAP TMS SA to Announce First Quarter 2020 Financial Results on May 13, 2020
2020-05-04 08:22:04 | How Does EDAP TMS S.A. NASDAQ:EDAP Affect Your Portfolio Volatility?
2020-04-04 08:50:07 | Time To Worry? One Analyst Just Downgraded Their EDAP TMS S.A. NASDAQ:EDAP Outlook
2020-03-31 06:30:00 | EDAP TMS SA to Host Earnings Call
2020-03-30 16:35:00 | EDAP Reports Record Full Year 2019 Results and Provides Operational Update
2020-03-30 07:00:43 | Can EDAP TMS S.A.'s NASDAQ:EDAP ROE Continue To Surpass The Industry Average?
2020-01-29 08:30:00 | EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami
2020-01-09 08:30:00 | EDAP Issues Letter to Shareholders
2019-12-31 11:46:45 | Is Now An Opportune Moment To Examine EDAP TMS S.A. NASDAQ:EDAP?
2019-12-20 10:45:52 | Hedge Funds Have Never Been This Bullish On EDAP TMS S.A. EDAP
2019-11-26 08:29:00 | EDAP Announces First Focal One® HIFU treatments at Farrer Park Hospital in Singapore
2019-11-18 09:00:02 | EDAP TMS S.A. EDAP Moves to Buy: Rationale Behind the Upgrade
2019-11-14 06:01:32 | What You Must Know About EDAP TMS S.A.'s NASDAQ:EDAP Beta Value
2019-11-13 16:32:00 | EDAP Reports 2019 Third Quarter and Nine Months Results
2019-09-30 07:33:09 | What EDAP TMS S.A.'s NASDAQ:EDAP ROE Can Tell Us
2019-09-26 08:31:12 | Will EDAP TMS Continue to Surge Higher?
2019-09-20 10:40:02 | Top Ranked Momentum Stocks to Buy for September 20th
2019-09-06 10:07:02 | EDAP TMS S.A. EDAP Shares March Higher, Can It Continue?
2019-09-06 09:00:01 | EDAP TMS S.A. EDAP Upgraded to Strong Buy: Here's Why
2019-08-30 07:39:59 | Why EDAP TMS S.A.’s NASDAQ:EDAP Use Of Investor Capital Doesn’t Look Great
2019-08-28 16:44:29 | EDAP Reports 2019 Second Quarter Results
2019-07-26 12:31:10 | EDAP TMS NASDAQ:EDAP May Be Weighed Down By Its Debt
2019-07-25 08:00:00 | EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019
2019-05-15 16:35:00 | EDAP Reports 2019 First Quarter Results
2019-05-14 17:14:00 | EDAP TMS Expected to Earn 2 Cents a Share
2019-05-02 08:00:00 | EDAP TMS SA to Announce First Quarter 2019 Financial Results on Wednesday, May 15, 2019
2019-04-26 14:49:48 | Introducing EDAP TMS NASDAQ:EDAP, The Stock That Zoomed 117% In The Last Year
2019-04-10 08:39:12 | EDAP TMS EDAP Looks Good: Stock Adds 7.9% in Session
2019-04-02 17:50:36 | Dow Jones Falls on Tuesday
2019-04-02 06:30:00 | EDAP TMS SA Sponsored ADR to Host Earnings Call
2019-04-01 16:35:00 | EDAP TMS SA : EDAP Reports Q4 and Full Year 2018 Results
2019-04-01 08:00:54 | EDAP TMS SA : University of Chicago Medicine Becomes First Hospital in the Midwest to Acquire Breakthrough Focal One® HIFU Advanced Robotic Technology for Prostate Cancer Treatment
2019-01-22 11:59:02 | What Kind Of Shareholders Own EDAP TMS S.A. NASDAQ:EDAP?
2019-01-14 08:00:42 | EDAP TMS SA : EDAP Announces Sales of Two Additional Focal One® Devices in Brazil